论文部分内容阅读
目的对腹腔镜下子宫肌瘤剔除术与开腹手术的临床疗效展开对比。方法择选我院2015年11月至2016年11月所收治的60例子宫肌瘤患者作为本文研究对象,按随机数字表法分成研究组与对照组,两组各30例。其中,对照组患者采用开腹手术进行治疗,研究组患者采用腹腔镜下子宫肌瘤剔除术进行治疗,对两组患者的临床疗效展开观察与对比。结果经治疗结果得出,研究组患者的术中出血量要明显少于对照组患者,组间结果存在显著性差异,有统计学意义(P<0.05);在手术时间、首次排气时间及住院时间上,研究组患者的所用时间均短于对照组患者,组间结果存在显著性差异,有统计学意义(P<0.05);在术后并发症上,对照组中共有14例患者出现并发症,研究组中仅有2例患者出现并发症现象,对照组患者的术后并发症发生率要明显高于研究组患者,组间结果存在显著性差异,有统计学意义(P<0.05)。结论针对子宫肌瘤患者采用腹腔镜下子宫肌瘤剔除术进行治疗能够减少对患者身体带来的创伤,改善术后预后效果,减少患者术后并发症现象,对患者病症康复有良好保障。
Objective To compare the clinical efficacy of laparoscopic myomectomy and laparotomy. Methods Sixty patients with uterine fibroids who were treated in our hospital from November 2015 to November 2016 were selected as the study object and divided into study group and control group according to random number table method, with 30 cases in each group. Among them, patients in the control group were treated with laparotomy, and patients in the study group were treated with laparoscopic myomectomy. The clinical effects of the two groups were observed and compared. Results The results of the treatment showed that the amount of intraoperative blood loss in the study group was significantly less than that in the control group. There was significant difference between the groups (P <0.05); at the time of operation, the time of the first exhaust and Hospitalization time, the study group patients were shorter than the control group patients, the results showed significant differences between groups, with statistical significance (P <0.05); in the postoperative complications, a total of 14 patients in the control group Complications, only two patients in the study group had complications, the incidence of postoperative complications in the control group was significantly higher than that in the study group, there was a significant difference between the two groups (P <0.05 ). Conclusion The treatment of hysteromyoma patients with laparoscopic myomectomy can reduce the trauma to the patient’s body, improve the prognosis and reduce the postoperative complications of patients with good protection of the disease recovery.